Lobetyolin Suppressed Osteoclastogenesis and Alleviated Bone Loss in Ovariectomy-Induced Osteoporosis via Hindering p50/p65 Nuclear Translocation and Downstream NFATc1/c-Fos Expression

Lobetyolin Suppressed Osteoclastogenesis and Alleviated Bone Loss in Ovariectomy-Induced Osteoporosis via Hindering p50/p65 Nuclear Translocation and Downstream NFATc1/c-Fos Expression

Chunmei Xiu,1,2,* Hua Luo,3,* Weixing Huang,4,5,* Shaohua Fan,3 Chiting Yuan,3 Jiangjie Chen,3 Chenghao Xu,3 Can Yao,3 Dun Hong,1,3 Liwei Zhang1,3 1Institute of Bone Metabolism, Taizhou Hospital of Zhejiang Province, School of Medicine, Zhejiang University, Taizho...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiu C, Luo H, Huang W, Fan S, Yuan C, Chen J, Xu C, Yao C, Hong D, Zhang L
Format: Article
Language:English
Published: Dove Medical Press 2025-06-01
Series:Drug Design, Development and Therapy
Subjects:
Postmenopausal osteoporosis
Osteoclast
Lobetyolin
Inflammation
Osteoblast
Online Access:https://www.dovepress.com/lobetyolin-suppressed-osteoclastogenesis-and-alleviated-bone-loss-in-o-peer-reviewed-fulltext-article-DDDT
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items